TY - JOUR
T1 - Laparoendoscopic single-site surgery (LESS) in gynecology
T2 - A multi-institutional evaluation
AU - Fader, Amanda Nickles
AU - Rojas-Espaillat, Luis
AU - Ibeanu, Okechukwu
AU - Grumbine, Francis C.
AU - Escobar, Pedro F.
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2010/11
Y1 - 2010/11
N2 - Objective: The study objectives were to determine the surgical outcomes of a large series of gynecology patients treated with laparoendoscopic single-site surgery (LESS). Study Design: This was a retrospective, multi-institutional analysis of gynecology patients treated with LESS in 2009. Patients underwent surgery via a single 1.5- to 2.5-cm umbilical incision with a multichannel single port. Results: A total of 74 women underwent LESS. Procedures were performed for benign pelvic masses (n = 39), endometrial hyperplasia (n = 9), endometrial (n = 15) and ovarian (n = 6) cancers, and nongynecologic malignancies (n = 5). Median patient age and body mass index were 47 years and 28, respectively. A Pearson product-moment correlation coefficient was computed and demonstrated a significant linear relationship between the operating time and number of cases for cancer staging (r = 0.71; n = 26; P < .001) and nonstaging (r = 0.78; n = 48; P < .002) procedures. Perioperative complications were low (3%). Conclusion: LESS is feasible, safe, and reproducible in gynecology patients with benign and cancerous conditions. Operative times are reasonable and can be decreased with experience.
AB - Objective: The study objectives were to determine the surgical outcomes of a large series of gynecology patients treated with laparoendoscopic single-site surgery (LESS). Study Design: This was a retrospective, multi-institutional analysis of gynecology patients treated with LESS in 2009. Patients underwent surgery via a single 1.5- to 2.5-cm umbilical incision with a multichannel single port. Results: A total of 74 women underwent LESS. Procedures were performed for benign pelvic masses (n = 39), endometrial hyperplasia (n = 9), endometrial (n = 15) and ovarian (n = 6) cancers, and nongynecologic malignancies (n = 5). Median patient age and body mass index were 47 years and 28, respectively. A Pearson product-moment correlation coefficient was computed and demonstrated a significant linear relationship between the operating time and number of cases for cancer staging (r = 0.71; n = 26; P < .001) and nonstaging (r = 0.78; n = 48; P < .002) procedures. Perioperative complications were low (3%). Conclusion: LESS is feasible, safe, and reproducible in gynecology patients with benign and cancerous conditions. Operative times are reasonable and can be decreased with experience.
KW - laparoendoscopic single-site surgery (LESS)
KW - single-port laparoscopy
KW - single-port surgery
UR - http://www.scopus.com/inward/record.url?scp=78149283320&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78149283320&partnerID=8YFLogxK
U2 - 10.1016/j.ajog.2010.06.028
DO - 10.1016/j.ajog.2010.06.028
M3 - Article
C2 - 20663487
AN - SCOPUS:78149283320
SN - 0002-9378
VL - 203
SP - 501.e1-501.e6
JO - American Journal of Obstetrics and Gynecology
JF - American Journal of Obstetrics and Gynecology
IS - 5
ER -